Edition:
United Kingdom

Cesca Therapeutics Inc (KOOL.OQ)

KOOL.OQ on NASDAQ Stock Exchange Capital Market

0.37USD
19 Oct 2018
Change (% chg)

-- (--)
Prev Close
$0.37
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
86,987
52-wk High
$4.14
52-wk Low
$0.22

Chart for

About

Cesca Therapeutics Inc. is clinical-stage biotechnology company. The Company develops and markets integrated cellular therapies and delivery systems. The Company is engaged in developing and manufacturing of automated blood and bone marrow processing systems that enable the separation, processing and preservation of cell and... (more)

Overall

Beta: -0.75
Market Cap(Mil.): $45.06
Shares Outstanding(Mil.): 9.95
Dividend: --
Yield (%): --

Financials

  KOOL.OQ Industry Sector
P/E (TTM): -- 30.90 33.64
EPS (TTM): -4.38 -- --
ROI: -67.06 14.75 14.27
ROE: -92.20 16.24 15.99

BRIEF-Cesca Therapeutics Says Offering Up To 3.2 Million Units

* CESCA THERAPEUTICS SAYS OFFERING UP TO 3.2 MILLION UNITS, EACH UNIT CONSISTING OF 1 SHARE OF COMMON STOCK, ONE COMMON WARRANT TO PURCHASE 1 SHARE OF STOCK Source text: (https://bit.ly/2I8M01T) Further company coverage:

08 May 2018

BRIEF-Cesca Therapeutics Announces Evaluation Agreement With The University Of North Carolina For X-Series Products

* CESCA THERAPEUTICS ANNOUNCES EVALUATION AGREEMENT WITH THE UNIVERSITY OF NORTH CAROLINA LINEBERGER ADVANCED CELLULAR THERAPEUTICS FACILITY FOR X-SERIES™ PRODUCTS THAT PROVIDE AUTOMATED, CLOSED SYSTEM CELLULAR PROCESSING

24 Apr 2018

Earnings vs. Estimates